Below are the most recent publications written about "Renal Insufficiency" by people in Profiles.
-
Lunsford KE, Bodzin AS, Markovic D, Zarrinpar A, Kaldas FM, Gritsch HA, Xia V, Farmer DG, Danovitch GM, Hiatt JR, Busuttil RW, Agopian VG. Avoiding Futility in Simultaneous Liver-kidney Transplantation: Analysis of 331 Consecutive Patients Listed for Dual Organ Replacement. Ann Surg. 2017 05; 265(5):1016-1024.
-
Davies SJ, Caskey FJ, Coyle D, Lindley E, Macdonald J, Mitra S, Wilkie M, Davenport A, Farrington K, Dasgupta I, Ormandy P, Andronis L, Solis-Trapala I, Sim J. Rationale and design of BISTRO: a randomized controlled trial to determine whether bioimpedance spectroscopy-guided fluid management maintains residual kidney function in incident haemodialysis patients. BMC Nephrol. 2017 Apr 26; 18(1):138.
-
Post FA, Tebas P, Clarke A, Cotte L, Short WR, Abram ME, Jiang S, Cheng A, Das M, Fordyce MW. Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study. J Acquir Immune Defic Syndr. 2017 Feb 01; 74(2):180-184.
-
Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Liu N, Wilson CM, Hazra R, Hosek SG, Anderson PL, Seifert SM, Kapogiannis BG, Mulligan K. Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis. Clin Infect Dis. 2017 Feb 01; 64(3):317-325.
-
Nazarian SM, Reese PP. Insights from a ten-year, prospective study of live kidney donors. Transpl Int. 2015 Nov; 28(11):1265-7.
-
Qaseem A, Wilt TJ, Cooke M, Denberg TD. The paucity of evidence supporting screening for stages 1-3 CKD in asymptomatic patients with or without risk factors. Clin J Am Soc Nephrol. 2014 Nov 07; 9(11):1993-5.
-
Bagnasco SM, Zachary AA, Racusen LC, Arend LJ, Carter-Monroe N, Alachkar N, Nazarian SM, Lonze BE, Montgomery RA, Kraus ES. Time course of pathologic changes in kidney allografts of positive crossmatch HLA-incompatible transplant recipients. Transplantation. 2014 Feb 27; 97(4):440-5.
-
Sethi S, Relia N, Syal G, Kaushik C, Gokden N, Malik AB. Progressive kidney failure as the sole manifestation of extrapulmonary sarcoidosis. J Ark Med Soc. 2013 Sep; 110(4):64-6.
-
Whellan DJ, Cox M, Hernandez AF, Heidenreich PA, Curtis LH, Peterson ED, Fonarow GC. Utilization of hospice and predicted mortality risk among older patients hospitalized with heart failure: findings from GWTG-HF. J Card Fail. 2012 Jun; 18(6):471-7.
-
Gaballa MR, Laubach JP, Schlossman RL, Redman K, Noonan K, Mitsiades CS, Ghobrial IM, Munshi N, Anderson KC, Richardson PG. Management of myeloma-associated renal dysfunction in the era of novel therapies. Expert Rev Hematol. 2012 Feb; 5(1):51-66; quiz 67-8.